📌EU’s new red yeast rice supplements regulation has changed and is now effective! (20220624)
Breaking News! We are the 2024 NutraIngredient USA Awards Finalist! (20230528)
President Commends SunWay Biotech as ANKASCIN® 568-R Red Yeast Rice Extract Wins SNQ Bronze Award. (20240417)
【Statement】SunWay Biotech Co., Ltd.’s red yeast rice raw material ANKASCIN 568-R is safe in quality and source. (20240326)
SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch New ANKASCIN®/MenaQ7 Product: MenaQ7® Metabolic! (20230314)
ANKASCIN 568 Ingredient Description
ANKASCIN 568-R is extracted from fermented products of patented functional red yeast strain Monascus purpureus NTU 568 and studied for more than ten years by the research team of Professor Tzu-Ming Pan from National Taiwan University. Unlike conventional manual fermentation with derivative quality instability, this premium ingredient is the only red yeast fermented extract manufactured using an exclusive automated solid state fermentation technique. ANKASCIN 568-R is FREE of risky lovastatin/monacolin K but contains high levels of another two new active compounds (Monascin and Ankaflavin). Science basis is perfectly supported by more than 120 related SCI publications, including a large number of animal and clinical studies verifying its effects on regulation of blood lipids, blood glucose, blood pressure, prevention and treatment of Alzheimer’s Disease, etc. It was also certified with plenty of patents from the USA, EU, Canada, Japan, Australia, China, Korea, Singapore, Taiwan, etc. In 2015, this ingredient was honorably reviewed and accepted by the US FDA as a NEW DIETARY INGREDIENT (NDI), which made it the only eligible red yeast ingredient on the US market that could legally apply claims and clearly specify the contents of active compounds. Therefore, it is greatly suitable for formulation of dietary supplements and fortified foods.
Vigiis 101 Ingredient Description
Vigiis101-LAB contains an excellent patented functional strain Lactobacillus paracasei subsp. paracasei NTU 101, which is studied for more than ten years by the research team of Professor Tzu-Ming Pan from National Taiwan University. It is isolated from the intestinal microbial flora of breast-fed infants in 3 days after birth and it possesses strong tolerance to gastric acid and bile salts so there is no need for microencapsulation. Its fermented products on enhancing digestion, improvement in gastrointestinal microbiota, modulation of immune system and allergic reaction, etc.
Contact us → Establishing a product developing group → Market research → Product conceptualization and selection → Product design → Sample production → Sample testing and price offer → Memorandum of understanding for further cooperation → Designing mass manufacturing procedures → Mass production tests → Confirmation of production assessment → OEM contracting → Sourcing ingredients and materials → Production and quality assurance → Warehousing and quality control → Delivery → Final reports
More